$52.50 (-0.474%)

Volume: 190.662k

Closed: Feb 03, 2023

Hollow Logo Score: 3.113
Enanta Pharmaceuticals Stock
$52.50 (-0.474%)

Volume: 190.662k

Closed: Feb 03, 2023

Score Hollow Logo 3.113
NASDAQ:ENTA

Enanta Pharmaceuticals Stock Price (Quote)

$52.50 ( -0.474% ) Friday, 3rd Feb 2023

Range Low Price High Price Comment
30 days $44.48 $54.48 Friday, 3rd Feb 2023 ENTA stock ended at $52.50. This is 0.474% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 5.23% from a day low at $51.42 to a day high of $54.11.
90 days $39.60 $54.48
52 weeks $37.59 $79.50

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
2023-02-03 $51.80 $54.11 $51.42 $52.50 190 662
2023-02-02 $52.46 $54.48 $52.46 $52.75 192 285
2023-02-01 $53.29 $54.20 $50.14 $51.91 132 009
2023-01-31 $51.42 $53.70 $50.39 $53.38 189 682
2023-01-30 $51.74 $52.22 $50.65 $50.95 104 600
2023-01-27 $51.34 $52.20 $50.40 $52.02 104 986
2023-01-26 $51.67 $52.60 $50.15 $51.51 83 468
2023-01-25 $51.07 $52.44 $50.35 $51.49 136 755
2023-01-24 $49.45 $52.73 $49.45 $51.82 130 220
2023-01-23 $50.21 $50.86 $48.96 $49.54 136 142
2023-01-20 $51.18 $51.18 $48.80 $50.28 224 429
2023-01-19 $49.04 $51.19 $48.02 $50.40 115 039
2023-01-18 $48.62 $51.45 $48.33 $49.21 192 700
2023-01-17 $51.56 $51.56 $48.12 $48.22 166 310
2023-01-13 $51.95 $54.09 $49.61 $51.46 180 800
2023-01-12 $50.96 $53.69 $49.86 $52.54 248 521
2023-01-11 $48.13 $50.67 $47.76 $50.55 115 933
2023-01-10 $47.02 $48.81 $47.02 $48.15 176 600
2023-01-09 $50.03 $50.50 $46.80 $47.19 170 200
2023-01-06 $46.71 $49.95 $45.86 $49.74 164 800
2023-01-05 $45.75 $47.49 $44.48 $46.58 115 309
2023-01-04 $45.83 $47.48 $45.25 $46.34 89 694
2023-01-03 $46.73 $47.06 $45.21 $45.75 76 972
2022-12-30 $46.67 $46.88 $45.23 $46.52 81 026
2022-12-29 $45.95 $47.88 $45.54 $46.86 127 355
2022-12-28 $45.12 $46.26 $44.87 $45.48 67 038
2022-12-27 $46.96 $46.96 $43.98 $45.02 81 389
2022-12-23 $47.16 $47.64 $45.70 $47.06 108 074
2022-12-22 $46.47 $47.35 $45.23 $47.24 120 325
2022-12-21 $46.72 $47.93 $46.04 $46.95 135 588
2022-12-20 $42.53 $47.00 $42.53 $46.76 146 757
2022-12-19 $44.84 $45.81 $40.89 $42.78 263 799
2022-12-16 $43.29 $45.79 $43.09 $45.36 394 672
2022-12-15 $44.16 $44.31 $43.19 $43.84 158 243
2022-12-14 $43.58 $44.80 $43.18 $44.49 169 621
2022-12-13 $43.70 $44.45 $42.59 $43.84 104 947
2022-12-12 $41.58 $42.83 $40.92 $42.75 116 114
2022-12-09 $42.81 $42.81 $41.34 $41.70 114 278
2022-12-08 $42.43 $42.53 $40.92 $41.96 92 687
2022-12-07 $42.35 $43.23 $42.00 $42.41 91 408
2022-12-06 $42.76 $42.92 $41.73 $42.37 121 006
2022-12-05 $45.12 $45.12 $42.66 $43.06 104 893
2022-12-02 $43.98 $45.50 $43.92 $45.24 102 075
2022-12-01 $44.01 $45.15 $43.51 $44.62 103 792
2022-11-30 $42.64 $44.00 $40.06 $43.79 186 153
2022-11-29 $41.10 $42.83 $40.63 $41.96 428 040
2022-11-28 $41.21 $41.70 $39.60 $41.13 247 316
2022-11-25 $44.47 $45.89 $40.95 $41.58 138 732
2022-11-23 $45.59 $46.23 $43.80 $45.00 283 556
2022-11-22 $41.94 $46.42 $40.15 $45.44 239 849

Hot Stocks To Watch:

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT